TrialClinical pharmacokinetics2004

Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.

Kenneth C Lasseter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.